- Home
- / Skye Bioscience
Skye Bioscience
Stock Price
$0.1
2021-03-19
Market Capitalization
$22.5 M
2021-03-19
Skye Bioscience Summary
Company Summary
- Overview
- Skye Bioscience (formerly Nemus Bioscience, Emerald Bioscience) is a biopharmaceutical company focused on the discovery, development, and commercialization of cannabinoid-based therapeutics. It develops therapies for diseases such as glaucoma, MRSA infection, dry eye syndrome, etc.
- Type
- Public
- Status
- Active
- Founded
- 2012
- HQ
- Long Beach, CA, US | view all locations
- Website
- https://skyebioscience.com/
- Cybersecurity rating
Table of Contents
Key People
Kaitlyn Arsenault, CFO
Tu Diep, Chief Development Officer
Tom Kim, General Counsel and Director of IP
LocationsView all
2 locations detected
Long Beach, CA HQ
United States
130 N Marina Dr
San Diego, CA
United States
11250 El Camino Real Ste 100
Skye Bioscience Financials
Summary Financials
- Net income (Q1, 2026)
- ($12.5M)
- Cash (Q1, 2026)
- $8.1M
- EBIT (Q1, 2026)
- ($12.7M)
- Enterprise value
- $14.7M